DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Muro K, Chung HC, Shankaran V. et al.
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): A multicentre, open-label, phase 1b trial.
Lancet Oncol 2016;
17: 717-726
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.